I took this off TCOYD’s website:

The FDA just approved the first-ever disease-modifying therapy for type 1 diabetes! It is called Tzield (teplizumab) and is indicated to delay the onset of type 1 diabetes in adults and pediatric patients aged 8 years and older who are at high risk of getting type 1. The average delay in the onset of T1D observed in the clinical study evaluating the safety and efficacy of Tzield was approximately 3 years!

Thanks to this breakthrough in diabetes treatment, individuals who are at risk of developing type 1 diabetes—especially first-and-second degree relatives of someone who has type 1—can get screened for the antibodies that predict the onset of T1D. If they test positive for the antibodies, they can look into Tzield as a potential therapeutic option to delay the onset of T1D.

There are many ways you can get screened for T1D, including at home kits that utilize a simple finger stick for blood. The type1tested.com website is a fantastic place to learn more about Tzield and the different screening options.